Cargando…

Feasibility and diagnostic performance of dual-tracer-guided sentinel lymph node biopsy in cT1-2N0M0 gastric cancer: a systematic review and meta-analysis of diagnostic studies

BACKGROUND: Dual-tracer-guided sentinel lymph node (SLN) biopsy may provide a promising diagnostic tool to assess accurately the status of lymph node metastasis in the surgical operation and assure the oncologic safety of the function or stomach preserving surgery. The diagnostic performance of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Ling, Wei, Tao, Chen, Junjun, Zhou, Donghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434631/
https://www.ncbi.nlm.nih.gov/pubmed/28511723
http://dx.doi.org/10.1186/s12957-017-1159-7
_version_ 1783237087793774592
author Huang, Ling
Wei, Tao
Chen, Junjun
Zhou, Donghui
author_facet Huang, Ling
Wei, Tao
Chen, Junjun
Zhou, Donghui
author_sort Huang, Ling
collection PubMed
description BACKGROUND: Dual-tracer-guided sentinel lymph node (SLN) biopsy may provide a promising diagnostic tool to assess accurately the status of lymph node metastasis in the surgical operation and assure the oncologic safety of the function or stomach preserving surgery. The diagnostic performance of this technology in recent studies varied. Thus, we conducted this meta-analysis. METHODS: This systematic review and meta-analysis was registered at the PROSPERO. Eligible studies were searched in the PubMed, EMBASE, Web of Knowledge, and Cochrane Library databases. A random-effect model was used to pool the data. Summary receiver operator characteristic curves, analysis for publication bias, meta-regression, and subgroup analysis were also performed. RESULTS: The pooled SLN identification rate and sensitivity were 0.97 and 0.89. (99m)Tc-human serum albumin with indocyanine green (ICG), (99m)Tc-antimony sulfur colloid with ICG, performing SLN biopsy ≥15 min after dye injection, an SLN ≥5, the basin dissection, laparoscopic surgery, in studies conducted in Japan and studies published after 2012, were associated with higher sensitivity. CT1 stage, performing SLN biopsy ≥15 min after dye injection, in studies conducted in Japan and studies published after 2012, were related with a higher identification rate. CONCLUSIONS: Dual tracer is promising in SLN biopsy in gastric cancer, and the clinical application of SLN biopsy should be limited to the patients of cT1N0M0 gastric cancer. The combination of (99m)Tc-human serum albumin and ICG as well as the combination of (99m)Tc-antimony sulfur colloid and ICG may be the optimal tracer combination. However, it seems not justified to put this technique into routine clinical application recently. Some factors that might enhance diagnostic value are identified. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12957-017-1159-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5434631
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54346312017-05-18 Feasibility and diagnostic performance of dual-tracer-guided sentinel lymph node biopsy in cT1-2N0M0 gastric cancer: a systematic review and meta-analysis of diagnostic studies Huang, Ling Wei, Tao Chen, Junjun Zhou, Donghui World J Surg Oncol Review BACKGROUND: Dual-tracer-guided sentinel lymph node (SLN) biopsy may provide a promising diagnostic tool to assess accurately the status of lymph node metastasis in the surgical operation and assure the oncologic safety of the function or stomach preserving surgery. The diagnostic performance of this technology in recent studies varied. Thus, we conducted this meta-analysis. METHODS: This systematic review and meta-analysis was registered at the PROSPERO. Eligible studies were searched in the PubMed, EMBASE, Web of Knowledge, and Cochrane Library databases. A random-effect model was used to pool the data. Summary receiver operator characteristic curves, analysis for publication bias, meta-regression, and subgroup analysis were also performed. RESULTS: The pooled SLN identification rate and sensitivity were 0.97 and 0.89. (99m)Tc-human serum albumin with indocyanine green (ICG), (99m)Tc-antimony sulfur colloid with ICG, performing SLN biopsy ≥15 min after dye injection, an SLN ≥5, the basin dissection, laparoscopic surgery, in studies conducted in Japan and studies published after 2012, were associated with higher sensitivity. CT1 stage, performing SLN biopsy ≥15 min after dye injection, in studies conducted in Japan and studies published after 2012, were related with a higher identification rate. CONCLUSIONS: Dual tracer is promising in SLN biopsy in gastric cancer, and the clinical application of SLN biopsy should be limited to the patients of cT1N0M0 gastric cancer. The combination of (99m)Tc-human serum albumin and ICG as well as the combination of (99m)Tc-antimony sulfur colloid and ICG may be the optimal tracer combination. However, it seems not justified to put this technique into routine clinical application recently. Some factors that might enhance diagnostic value are identified. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12957-017-1159-7) contains supplementary material, which is available to authorized users. BioMed Central 2017-05-16 /pmc/articles/PMC5434631/ /pubmed/28511723 http://dx.doi.org/10.1186/s12957-017-1159-7 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Huang, Ling
Wei, Tao
Chen, Junjun
Zhou, Donghui
Feasibility and diagnostic performance of dual-tracer-guided sentinel lymph node biopsy in cT1-2N0M0 gastric cancer: a systematic review and meta-analysis of diagnostic studies
title Feasibility and diagnostic performance of dual-tracer-guided sentinel lymph node biopsy in cT1-2N0M0 gastric cancer: a systematic review and meta-analysis of diagnostic studies
title_full Feasibility and diagnostic performance of dual-tracer-guided sentinel lymph node biopsy in cT1-2N0M0 gastric cancer: a systematic review and meta-analysis of diagnostic studies
title_fullStr Feasibility and diagnostic performance of dual-tracer-guided sentinel lymph node biopsy in cT1-2N0M0 gastric cancer: a systematic review and meta-analysis of diagnostic studies
title_full_unstemmed Feasibility and diagnostic performance of dual-tracer-guided sentinel lymph node biopsy in cT1-2N0M0 gastric cancer: a systematic review and meta-analysis of diagnostic studies
title_short Feasibility and diagnostic performance of dual-tracer-guided sentinel lymph node biopsy in cT1-2N0M0 gastric cancer: a systematic review and meta-analysis of diagnostic studies
title_sort feasibility and diagnostic performance of dual-tracer-guided sentinel lymph node biopsy in ct1-2n0m0 gastric cancer: a systematic review and meta-analysis of diagnostic studies
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434631/
https://www.ncbi.nlm.nih.gov/pubmed/28511723
http://dx.doi.org/10.1186/s12957-017-1159-7
work_keys_str_mv AT huangling feasibilityanddiagnosticperformanceofdualtracerguidedsentinellymphnodebiopsyinct12n0m0gastriccancerasystematicreviewandmetaanalysisofdiagnosticstudies
AT weitao feasibilityanddiagnosticperformanceofdualtracerguidedsentinellymphnodebiopsyinct12n0m0gastriccancerasystematicreviewandmetaanalysisofdiagnosticstudies
AT chenjunjun feasibilityanddiagnosticperformanceofdualtracerguidedsentinellymphnodebiopsyinct12n0m0gastriccancerasystematicreviewandmetaanalysisofdiagnosticstudies
AT zhoudonghui feasibilityanddiagnosticperformanceofdualtracerguidedsentinellymphnodebiopsyinct12n0m0gastriccancerasystematicreviewandmetaanalysisofdiagnosticstudies